hotspot -WSS

hotspot

author：Wikipedia 2025-09-27 13:03:25 - browse：17

A pharmacist hands a box of Wegovy — first opinion coverage from STAT — Bloomberg photo by George Frey

LONDON — Novo Nordisk said Wednesday that it had started to increase the availability of its blockbuster obesity drug Wegovy for new patients in the United States, after massive demand and a supply crunch had led it to limit doses last May.

The announcement that Novo was making more of its lower-dose starter product available as of this month came as the company reported its 2023 earnings, with sales up by 36% and operating profit up 44% at constant exchange rates, driven by enormous sales of Wegovy and Ozempic, the company’s sister drug for diabetes. The company also projected double-digit growth in sales and operating profit for 2024.

“I am pleased to state that we are now enabling more new U.S. patients to initiate treatment by more than doubling the amount of lower-dose strength Wegovy compared to previous months,” Novo CEO Lars Fruergaard Jørgensen said on a call with reporters.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： What does generative AI mean for health care? We asked experts
Next article： Experts study whether long Covid risk adds up with each reinfection

hotspot

WSS

Will biotech layoffs continue through 2023?

CDC's new outbreak response network to include Northeastern

Ending health disparities requires full federal government, panel says

Why are Kaiser Permanente staff considering a strike?

Second xenotransplant done with gene

CommonSpirit Health keeps growing, even as it loses money

knowledge

hotspot

Wikipedia

Supreme Court strikes down use of affirmative action

As the dark side of IVF slowly comes into focus, even more transparency is needed

Biden outlines 'new path' to provide student loan relief after Supreme Court rejection

Bryan Kohberger seeks indictment dismissal in Idaho college killings case

Continuity nursing helped my family in our darkest PICU moments

Interest rates are at a 22

Alkermes shareholders re

Senators: Long

The cancer drug shortage isn’t new — and neither are the solutions

McConnell had minor fall 2 weeks ago, uses wheelchair periodically to get around: Sources

focus

Lasker Awards 2023: Winners in biomedical research

Second xenotransplant done with gene

Hearing on Medicare drug price negotiation gets unusually heated

Trader Joe's recalls 10K cases of broccoli cheddar soup over potential foreign material

STAT Virtual Event: Putting AI to the Test

Hearing on Medicare drug price negotiation gets unusually heated

hotspot

explore

focus

explore